spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SMi’s 5th Molecular Diagnostics Conference

9-11 July 2018
Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018.

The global molecular diagnostics market is forecasted to reach over US$10 billion in the next three years, at a CAGR of 9.1% from 2016 to 2021*. In an ever-evolving universe of molecular diagnostics, it is vital to keep up with emerging and developing technology, products and applications. Furthermore, companies must comply to the constantly change regulatory environment and tackle the challenging process if implementing these regulations.

SMi welcomes you to explore the expanding market opportunities, the least diagnostics advancements and regulatory requirements at the 5th Molecular Diagnostics Conference.

This event is CPD accredited.

#SMiMolecularDx

Speaker Line-Up includes Matthew Albert, Nicholas Dale, Ana Alfirevic, Ashfaq Gilkar, Ben Courtney, Professor Kewal Jain, Matthew Albert, Miro Venturi.

Key themes for molecular diagnostics 2018:

  • Regulatory changes, challenges and outlook
  • Advances in laboratory technologies, including: biochips, nanotechnologies and proteomic technologies
  • Personalised medicine & pharmacogenomics
  • Diagnostic methods at the point of care
  • Molecular Diagnostics in Prenatal, Infectious Disease and Cancer

(*The Market Report can be found here: https://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html.)

Who should attend?

Attendees will primarily be drawn from the following backgrounds/departments:

Molecular Diagnostic, Cancer Immunology, Immunobiology, Biomarkers, Radiation Oncology, Therapeutic Radiology, Translational Medicine, Translational Assays Technologies, Companion Diagnostics, Clinical Chemistry, Experimental Medicine and Diagnostics.

They will include Leads, Directors, Heads, Project Managers, Principal Investigators, Principal Scientists, Senior Scientists, Research Scientist, Professors, Researchers and Clinical Analysts, amongst others.

 
Print this page
Send to a friend
   
spacer
Industry Events

BIO-Europe® 2019 - 25th Annual International Partnering Conference

11-13 November 2019, Hamburg, Germany

The 25th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Learn more.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>


News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement